A very clever idea: a value-based agreement between drug company and, as our own Susan Raiola points out, the Medicare patient (though payer wins, too).
read full article ›An interesting piece (featuring our very own Roger Longman and Susan Raiola) on the growing focus on lung cancer drugs for value based deals.
read full article ›